In fact, TOP2 poisons that impede the re-ligation phase of the reaction cycle have been used in cancer therapy to take advantage of this TOP2 characteristic, resulting in an accumulation of TOP2-DNA adducts4,5. The gene discussed is TOP2A; the disease is cancer.